Edition:
India

McKesson Corp (MCK.N)

MCK.N on New York Stock Exchange

132.90USD
20 Jul 2018
Change (% chg)

$-0.91 (-0.68%)
Prev Close
$133.81
Open
$132.60
Day's High
$133.47
Day's Low
$131.50
Volume
500,960
Avg. Vol
444,152
52-wk High
$178.86
52-wk Low
$129.67

Select another date:

Mon, Apr 30 2018

BRIEF-McKesson Board Of Directors Elects Brad Lerman As New Independent Director

* MCKESSON BOARD OF DIRECTORS ELECTS BRAD LERMAN AS NEW INDEPENDENT DIRECTOR

BRIEF-McKesson Launches Multi-Year Strategic Growth Initiative; Reaffirms Fiscal 2018 Outlook

* MCKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; REAFFIRMS FISCAL 2018 OUTLOOK AND PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK

BRIEF-Polarityte Announces Appointment Of Mckesson’S Willie Bogan To Board Of Directors

* POLARITYTE ANNOUNCES APPOINTMENT OF MCKESSON’S WILLIE BOGAN TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Two-Part Note Offering

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL TWO-PART NOTE OFFERING OF UP TO EUR 750 MILLION - SEC FILING Source text : (http://bit.ly/2H0ogwC) Further company coverage:

BRIEF-McKesson Corp Files Preliminary Prospectus Supplement Related To A Potential Notes Due 2028

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL NOTES DUE 2028 OFFERING OF UP TO $600 MILLION - SEC FILING Source text : (http://bit.ly/2G22iIb) Further company coverage:

BRIEF-Mckesson Files Preliminary Prospectus Supplement Related To Potential Offering Of Notes

* MCKESSON CORP FILES PRELIMINARY PROSPECTUS SUPPLEMENT RELATED TO A POTENTIAL OFFERING OF NOTES DUE 2020 - SEC FILING Source text - http://bit.ly/2FUEDJW Further company coverage:

UPDATE 3-McKesson says drug prices competitive but not volatile like 2017

* Books tax benefit of $370 mln in 3rd quarter (Adds company commentary on generic drug prices, background, analyst quotes; updates stock prices)

CORRECTED-UPDATE 1-Drug distributor McKesson's quarterly profit beats estimates

Feb 1 McKesson Corp posted a better-than-expected quarterly profit, as the biggest U.S. drug distributor continues to benefit from its tie-up with Walmart .

BRIEF-McKesson Reports Q3 Adjusted Earnings Per Share $3.41

* Q3 GAAP EARNINGS PER SHARE $4.32 FROM CONTINUING OPERATIONS

Drug distributor McKesson posts 42.6 pct rise in quarterly profit

Feb 1 McKesson Corp, the biggest U.S. drug distributor, reported a 42.6 percent rise in quarterly profit on Thursday, partly helped by a $370 million tax benefit related to changes to U.S. tax laws.

Select another date: